[
    "any different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete.</p><p id=\"p0054\" num=\"0049\">Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The term \"and/or\" as used herein includes any and all combinations of one or more of the associated listed items.</p><p id=\"p0055\" num=\"0050\">Unless otherwise indicated, the experimental methods used in the examples of the present invention were conventional experimental methods, and the various reagent consumables used in the examples were all commercially available products.</p><p id=\"p0056\" num=\"0051\">In a first aspect of the present invention, there is provided an EGFRvIII-PDL1-GMCSF fusion protein, the fusion fragment of which comprises a human epidermal growth factor receptor type III mutant (EGFRvIII), programmed death ligand 1 (PD-L1) and granulocyte-macrophage colony stimulating factor (GM-CSF), the amino acid sequence of which is shown in SEQ ID NO.1, encoded by a nucleotide sequence shown in SEQ ID NO. 2.</p><p id=\"p0057\" num=\"0052\"><u>Amino acid sequence (SEQ ID NO.1, 453 residues,Expected MW with His-tag:50.73 kD)</u></p><p id=\"p0058\" num=\"0053\">MLEEKKGNYVVTDHAKFVAAWTLKAAALEEKKGNYVVTDHAKFVAAWTLKAAALEEKKGNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQEFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAE<u>GPNG</u>SGSGMWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE<u>LEHHHHHH</u></p><p id=\"p0059\" num=\"0054\"><u>Nucleotide sequence (SEQ ID NO. 2)</u></p><p id=\"p0060\" num=\"0055\"><u>CAT</u>ATGCTAGAGGAGAAGAAGGGCAACTACGTTGTGACCGATCACGCCAAGTTCGTGGCCGCCTGGACCCTGAAGGCCGCCGCCTTAGAAGAAAAAAAAGGGAACTATGTCGTGACGGACCATGCGAAATTTGTCGCGGCGTGGACATTGAAAGCGGCGGCGCTGGAGGAAAAGAAAGGTAATTATGTGGTGACAGATCACGGCTCGTGCGTCCGAGCCTGTGGGGCCGACAGCTATGAGATGGAGGAAGACGGCGTCCGCAAGTGTAAGAAGTGCGAAGGGCCTTGCCGCAAAGTGTGTAACGGAATAGGTATTGGTGAATTTAAAGACTCACTCTCCATAAATGCTACGAATATTAAACACTTCAAAAACTGCACCTCCATCAGTGGCGATCTCCACATCCTGCCGGTGGCATTTAGGGGTGACTCCTTCACACATACTCCTCCTCTGGATCCACAGGAATTTACTGTCACGGTTCCCAAGGACCTATATGTGGTAGAGTATGGTAGCAATATGACAATTGAATGCAAATTCCCAGTAGAAAAACAATTAGACCTGGCTGCACTAATTGTCTATTGGGAAATGGAGGATAAGAACATTATTCAATTTGTGCATGGAGAGGAAGACCTGAAGGTTCAGCATAGTAGCTACAGACAGAGGGCCCGGCTGTTGAAGGACCAGCTCTCCCTGGGAAATGCTGCACTTCAGATCACAGATGTGAAATTGCAGGATGCAGGGGTGTACCGCTGCATGATCAGCTATGGTGGTGCCGACTACAAGCGAATTACTGTGAAAGTCAATGCCCCATACAACAAAATCAACCAAAGAATTTTGGTTGTGGATCCAGTCACCTCTGAACATGAACTGACATGTCAGGCTGAGGGTCCGAAC"
]